Europe — EMA

Olumiant (Baricitinib)

Baricitinib, the active ingredient in Olumiant, is a Jan Jan presented as a tablet for oral use. It treats moderate to severe rheumatoid arthritis in adults who have responded inadequately to one or more…

Baricitinib

Request sourcing

Pack/s

What is Baricitinib?

GNH USA supplies Olumiant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Baricitinib used for?

Olumiib ... ... ... ..............................

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →